Get the Stockscreener App
3.64
32.36%
0.89
After Hours:
3.52
-0.12
-3.30%
Geovax Labs Inc stock is traded at $3.64, with a volume of 45.62M.
It is up +32.36% in the last 24 hours and up +211.11% over the past month.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.
See More
Previous Close:
$2.75
Open:
$3.82
24h Volume:
45.62M
Relative Volume:
10.42
Market Cap:
$12.64M
Revenue:
$2.49M
Net Income/Loss:
$-21.46M
P/E Ratio:
-0.1864
EPS:
-19.526
Net Cash Flow:
$-21.50M
1W Performance:
+195.93%
1M Performance:
+211.11%
6M Performance:
-62.86%
1Y Performance:
-85.73%
1-Day Range:
$3.53
$4.3099
1-Week Range:
$1.7801
$4.39
52-Week Range:
$0.9631
$34.75
Geovax Labs Inc Stock (GOVX) Company Profile
Name
Geovax Labs Inc
Sector
Industry
Phone
678-384-7220
Address
1955 LAKE PARK DRIVE, SMYRNA
Compare GOVX vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
3.64 | 9.55M | 2.49M | -21.46M | -21.50M | -19.53 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Downgrade | D. Boral Capital | Buy → Hold |
| Apr-15-25 | Reiterated | Alliance Global Partners | Buy |
| Apr-15-25 | Reiterated | D. Boral Capital | Buy |
| Nov-11-24 | Initiated | Alliance Global Partners | Buy |
| Jul-16-24 | Initiated | ROTH MKM | Buy |
| Nov-19-20 | Initiated | Maxim Group | Buy |
View All
Geovax Labs Inc Stock (GOVX) Latest News
GOVX Jumps As GeoVax Wins Bullish Ebola Vaccine Call - timothysykes.com
WHO Africa Chief Warns It's A 'Big Mistake' To Underestimate Ebola Outbreak As Deadly Virus Spreads Beyond Congo - Benzinga
GOVX Stock Jumps As Noble Capital Targets $10 On Ebola Vaccine Hopes - StocksToTrade
GOVX Stock Jumps As Noble Capital Reaffirms $10 Target - timothysykes.com
GeoVax Labs Q1 2026 Earnings: Significant EPS Beat Drives Stock SurgeExpert Momentum Signals - newser.com
GOVX Stock Price, Quote & Chart | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
Q1 2025 GeoVax Labs Inc Earnings Call Transcript - GuruFocus
Is GeoVax Labs (GOVX) Still a Buy After +15.92% Rally? 2026-05-20Trading Community - Newser
GeoVax Stock Higher As Company Highlights MVA Platform For Ebola Threats - Benzinga
GeoVax Highlights Need for Flexible Vaccine Platforms Amid Bundibugyo Ebola Outbreak - MEXC
GOVX Stock Became A Hot Biodefense Trade Amid Ebola, Hantavirus Concerns - Stocktwits
GeoVax Comments on Escalating Bundibugyo Ebola Outbreak and Growing Need for Flexible Biodefense Vaccine Platforms - Yahoo Finance
GeoVax Labs Announces Private Placement Offering with Pre-Funded and Common Stock Purchase Warrants – Details and Agreements Included - Minichart
GeoVax Raises $3 Million via Private Placement Financing - TipRanks
GeoVax Raises $2.7 Million Net in Private Placement of Pre-Funded and Common Warrants - TradingView
GeoVax (NASDAQ: GOVX) prices $3M warrant-based private financing - Stock Titan
Why is GeoVax Labs stock falling Tuesday? - MSN
Noble Financial Maintains GeoVax Labs(GOVX.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Why Is GeoVax Labs Stock Falling Tuesday? - Benzinga
GOVX Stock Sees Volatile Spike As Traders Eye Momentum - timothysykes.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight - TechStock²
GOVX stock soars 80%: Retail traders are piling in as Ebola, hantavirus risks resurface - MSN
12 Health Care Stocks Moving In Monday's Pre-Market Session - Sahm
GOVX Stock Chart | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
GeoVax Labs, Inc. announced that it has received $3 million in funding - marketscreener.com
GeoVax Raises $3 Million in Private Placement for Working Capital and General Corporate Purposes - MEXC
GeoVax Labs, Inc. announced that it expects to receive $3 million in funding - marketscreener.com
GeoVax Labs (NASDAQ: GOVX) asks shareholders to permit issuance of warrants converting to shares - Stock Titan
GeoVax Highlights Need for Domestic MVA Vaccine Infrastructure Amid Global Health Emergencies - citybuzz -
GeoVax Highlights Strategic Importance of Domestic MVA-Based Preparedness Infrastructure Amid Escalating Global Infectious Disease Threats - Yahoo Finance
GOVX Stock Rockets On Heavy Volume As Traders Pile In - StocksToTrade
GeoVax Announces $3 Million Private Placement Financing Priced At-the-Market Under Nasdaq Rules - The Globe and Mail
GeoVax Labs (GOVX) jumps 178% as traders refocus on mpox vaccine thesis after recent Q1 update - Quiver Quantitative
$GeoVax Labs (GOVX.US)$ Never trapped - Moomoo
GOVX Stock Volatility Draws Trader Attention Amid Weak Fundamentals - timothysykes.com
All you need to know about GeoVax Labs (GOVX) rating upgrade to buy - MSN
GeoVax Jumps Pre-market as Traders Eye Biotech’s Mpox Vaccine Push - TechStock²
$GeoVax Labs (GOVX.US)$ [Sob][Sob] Made some profit but it was a hidden loss, thank you everyone - Moomoo
$GeoVax Labs (GOVX.US)$ thank you - Moomoo
$GeoVax Labs (GOVX.US)$ havent sell all yet :) - Moomoo
Roth MKM Maintains GeoVax Labs(GOVX.US) With Buy Rating, Maintains Target Price $10 - Moomoo
All You Need to Know About GeoVax Labs (GOVX) Rating Upgrade to Buy - cnhinews.com
Armistice Capital reports 9.99% stake in GEOVAX Labs (GOVX) via Master Fund - Stock Titan
GeoVax Advances GEO-MVA Phase 3 Trial as First Quarter 2026 Loss Narrows - citybuzz -
GeoVax Reports Q1 2026 Net Loss $5.3M, Cash $1.3M, Advances GEO-MVA Phase 3 Plans - TradingView
GeoVax (GOVX) Q1 2026 loss steady as cash falls and GEO-MVA advances - Stock Titan
GeoVax Labs | 10-Q: Q1 2026 Earnings Report - Moomoo
GeoVax Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
GeoVax (GOVX) Q1 2026 shows flat loss but cash only into June - Stock Titan
GeoVax Reports First Quarter 2026 Financial Results and Highlights GEO-MVA Phase 3 Trial Implementation Plans - Yahoo Finance
Geovax Labs Inc Stock (GOVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.98%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):